Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Cook

Showing results (251-260 of 329) with videos related to

Pageof 33
Sort By:
Current Drug Metabolism|December 3, 2021
Identification and Quantification of MIDD0301 MetabolitesM S Rashid Roni, Nicolas M Zahn, Brandon N Mikulsky, et al.
Nature Neuroscience|September 1, 2015
Regulating anxiety with extrasynaptic inhibitionPaolo Botta, Lynda Demmou, Yu Kasugai, et al.
Molecules (Basel, Switzerland)|August 29, 2020
A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABA<sub>A</sub> ReceptorGuanguan Li, Amanda N Nieman, Md Yeunus Mian, et al.
ACS Pharmacology & Translational Science|December 21, 2020
Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma ModelsNicolas M Zahn, Brandon N Mikulsky, M S Rashid Roni, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 6, 2023
Freeze-dried nanocrystal dispersion of novel deuterated pyrazoloquinolinone ligand (DK-I-56-1): Process parameters and lyoprotectant selection through the stability studyJelena R Mitrović, Maja Bjelošević Žiberna, Aleksandar Vukadinović, et al.
Nature Neuroscience|November 26, 2015
Corrigendum: Regulating anxiety with extrasynaptic inhibitionPaolo Botta, Lynda Demmou, Yu Kasugai, et al.
Brain Research|January 30, 2014
Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effectsAleksandar Lj Obradović, Srđan Joksimović, Michael M Poe, et al.
ACS Pharmacology & Translational Science|February 21, 2022
Development of Inhaled GABA<sub>A</sub> Receptor Modulators to Improve Airway Function in Bronchoconstrictive DisordersNicolas M Zahn, M S Rashid Roni, Gene T Yocum, et al.
Pharmaceutics|August 28, 2021
Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based ApproachJelena R Mitrović, Branka Divović-Matović, Daniel E Knutson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2020
Nanocrystal dispersion of DK-I-56-1, a poorly soluble pyrazoloquinolinone positive modulator of α6 GABAA receptors: Formulation approach toward improved in vivo performanceJelena R Mitrović, Branka Divović, Daniel E Knutson, et al.
Pageof 33

Showing results (251-260 of 329) with videos related to

Sort By:
Pageof 33
Current Drug Metabolism|December 3, 2021
Identification and Quantification of MIDD0301 MetabolitesM S Rashid Roni, Nicolas M Zahn, Brandon N Mikulsky, et al.
Nature Neuroscience|September 1, 2015
Regulating anxiety with extrasynaptic inhibitionPaolo Botta, Lynda Demmou, Yu Kasugai, et al.
Molecules (Basel, Switzerland)|August 29, 2020
A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABA<sub>A</sub> ReceptorGuanguan Li, Amanda N Nieman, Md Yeunus Mian, et al.
ACS Pharmacology & Translational Science|December 21, 2020
Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma ModelsNicolas M Zahn, Brandon N Mikulsky, M S Rashid Roni, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 6, 2023
Freeze-dried nanocrystal dispersion of novel deuterated pyrazoloquinolinone ligand (DK-I-56-1): Process parameters and lyoprotectant selection through the stability studyJelena R Mitrović, Maja Bjelošević Žiberna, Aleksandar Vukadinović, et al.
Nature Neuroscience|November 26, 2015
Corrigendum: Regulating anxiety with extrasynaptic inhibitionPaolo Botta, Lynda Demmou, Yu Kasugai, et al.
Brain Research|January 30, 2014
Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effectsAleksandar Lj Obradović, Srđan Joksimović, Michael M Poe, et al.
ACS Pharmacology & Translational Science|February 21, 2022
Development of Inhaled GABA<sub>A</sub> Receptor Modulators to Improve Airway Function in Bronchoconstrictive DisordersNicolas M Zahn, M S Rashid Roni, Gene T Yocum, et al.
Pharmaceutics|August 28, 2021
Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based ApproachJelena R Mitrović, Branka Divović-Matović, Daniel E Knutson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2020
Nanocrystal dispersion of DK-I-56-1, a poorly soluble pyrazoloquinolinone positive modulator of α6 GABAA receptors: Formulation approach toward improved in vivo performanceJelena R Mitrović, Branka Divović, Daniel E Knutson, et al.
Pageof 33